Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants☆-Reference-Cited by-同舟云学术

Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants☆

Published:2001-07 Issue:1 Volume:64 Page:43-49
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Sivin Irving,Wan Livia,Ranta Sirpa,Alvarez Francisco,Brache Vivian,Mishell Daniel R,Darney Philip,Biswas Arijit,Diaz Soledad,Kiriwat Orawan,Anant Manee Piya,Klaisle Cynthia,Pavez Margarita,Schechter Janet

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference7 articles.

1. First week drug concentrations in women with levonorgestrel rod or Norplant® capsule implants;Sivin;Contraception,1997

2. Levonorgestrel concentrations during use of Levonorgestrel rod (LNG rod implants);Sivin;Contraception,1997

3. Population Council NDA 20–544 on file with the US Food and Drug Administration, 1996.

4. Clinical performance of a new two-rod levonorgestrel contraceptive implant;Sivin;Contraception,1997

5. Contraception with two levonorgestrel rod implants;Sivin;Contraception,1998

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter clinical trial;Contraception;2024-09

2. A Physiologically-Based Pharmacokinetic Simulation to Evaluate Approaches to Mitigate Efavirenz-Induced Decrease in Levonorgestrel Exposure with a Contraceptive Implant;Pharmaceutics;2024-08-07

3. Potential biomarkers to predict return to fertility after discontinuation of female contraceptives—looking to the future;Frontiers in Reproductive Health;2023-08-22

4. Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in Kenya;Frontiers in Reproductive Health;2023-06-13

5. Best Practice Contraception Care for Women with Obesity: A Review of Current Evidence;Seminars in Reproductive Medicine;2022-11